Related Experiment Videos

[Coagglutination test and its application to the rapid diagnosis of meningococcal meningitis]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|March 1, 1981
PubMed

Insights

A modified coagglutination test aids in detecting meningococcal antigens in spinal fluid. This rapid diagnostic method is recommended for identifying meningococcal meningitis, especially early in the disease.

Area of Science:

  • Microbiology
  • Immunology
  • Clinical Diagnostics

Background:

  • Meningococcal meningitis diagnosis can be challenging, especially when antibiotic treatment precedes laboratory confirmation.
  • Rapid and accurate detection of Neisseria meningitidis antigens is crucial for timely treatment.

Purpose of the Study:

  • To develop and evaluate a modified slide coagglutination test for detecting meningococcal group-specific antigens in cerebrospinal fluid (CSF).
  • To assess the test's efficacy in diagnosing meningococcal meningitis, particularly in patients receiving antibiotics.

Main Methods:

  • Conjugation of group-specific meningococcal antisera (A, C, X, Y, Z) with formalin-treated Staphylococcus aureus (Cowan-I).
  • Inclusion of a 5-minute boiling step for CSF specimens to minimize non-specific reactions.
  • Testing 111 CSF specimens from 75 patients with suspected meningococcal meningitis and a control group.

Main Results:

  • The modified coagglutination test showed a positive result in 56.7% of patients.
  • Positive results reached 71% within the first 4 days of illness.
  • Control group CSF specimens yielded a maximum of 2% positive results, indicating high specificity.

Conclusions:

  • The modified slide coagglutination test is a sensitive and specific method for rapid diagnosis of meningococcal meningitis.
  • The test is particularly valuable in identifying the disease early and in cases where bacterial culture is negative due to prior antibiotic use.

Related Concept Videos